Common use of Action to Protect the Government’s Interest Clause in Contracts

Action to Protect the Government’s Interest. Regeneron agrees to execute or to have executed and promptly deliver to the Government all instruments necessary to (i) establish or confirm the rights the Government has throughout the world in those Subject Inventions to which Regeneron elects to retain title, and (ii) convey title to the Government when requested under Subparagraph c of this Section 7.2 and to enable the Government to obtain patent protection throughout the world in that Subject Invention. i. Regeneron agrees to require, by written agreement, its employees, other than clerical and non-technical employees, to disclose promptly in writing to personnel identified as responsible for the administration of patent matters and in a format suggested by Regeneron, each Subject Invention made under this Agreement so Regeneron can comply with the disclosure provisions of this Section 7.2. Regeneron shall use reasonable efforts to instruct employees, through employee agreements or other suitable educational programs, on the importance of reporting inventions in sufficient time to permit the filing of patent applications prior to U.S. or foreign statutory bars. ii. Regeneron shall notify the Government of any decisions not to continue the prosecution of a patent application for a Subject Invention, pay maintenance fees, or defend in a reexamination or opposition proceedings on a patent of a Subject Invention, in any country, not less than thirty (30) calendar days before the expiration of the response period required by the relevant patent office. Regeneron shall include, within the specification of any United States patent application and any patent issuing thereon covering a Subject Invention, the following statement: “This invention was made with Government support under Agreement MCDC2020-504, awarded by the U.S. Department of Health and Human Services. The Government has certain rights in the invention.”

Action to Protect the Government’s Interest. Regeneron 1. The Performer agrees to execute or to have executed and promptly deliver to the Government DARPA all instruments necessary to (i) establish or confirm the rights the Government has throughout the world in those Subject Inventions to which Regeneron the Performer elects to retain title, and (ii) convey title to the Government DARPA when requested under Subparagraph c paragraph D of this Section 7.2 Article and to enable the Government to obtain patent protection throughout the world in that Subject Invention. i. Regeneron 2. The Performer agrees to require, by written agreement, its employees, other than clerical and non-technical employees, to disclose promptly in writing to personnel identified as responsible for the administration of patent matters and in a format suggested by Regeneron, the Performer each Subject Invention made under this Agreement so Regeneron in order that the Performer can comply with the disclosure provisions of paragraph C of this Section 7.2Article. Regeneron The Performer shall use reasonable efforts to instruct employees, through employee agreements or other suitable educational programs, on the importance of reporting inventions in sufficient time to permit the filing of patent applications prior to U.S. U. S. or foreign statutory bars. ii3. Regeneron The Performer shall notify the Government DARPA of any decisions not to continue the prosecution of a patent application for a Subject Inventionapplication, pay maintenance fees, or defend in a reexamination or opposition proceedings on a patent of a Subject Inventionpatent, in any country, not less than thirty (30) calendar days before the expiration of the response period required by the relevant patent office. 4. Regeneron The Performer shall include, within the specification of any United States patent application and any patent issuing thereon covering a Subject Invention, the following statement: “This invention was made with Government support under Agreement MCDC2020HR0011-50412-3-0006, awarded by the U.S. Department of Health and Human ServicesDARPA. The Government has certain rights in the invention.”

Action to Protect the Government’s Interest. Regeneron i. Subcontractor agrees to execute or to have executed and promptly deliver to the Government all instruments necessary to (ia) establish or confirm the rights the Government has throughout the world in those Subject Inventions to which Regeneron Subcontractor elects to retain title, and (iib) convey title to the Government when requested under Subparagraph c of this Section 7.2 8(C) and to enable the Government to obtain patent protection throughout the world in that Subject Invention. i. Regeneron ii. Subcontractor agrees to require, by written agreement, its employees, other than clerical and non-non- technical employees, to disclose promptly in writing to personnel identified as responsible for the administration of patent matters and in a format suggested by Regeneron, Subcontractor each Subject Invention made under this Agreement so Regeneron in order that Subcontractor can comply with the disclosure provisions of this Section 7.28(B). Regeneron Subcontractor shall use reasonable efforts to instruct employees, through employee agreements or other suitable educational programs, on the importance of reporting inventions in sufficient time to permit the filing of patent applications prior to U.S. or foreign statutory bars. iiiii. Regeneron Subcontractor shall notify the Government of any decisions not to continue the prosecution of a patent application for a Subject Invention, pay maintenance fees, or defend in a reexamination or opposition proceedings on a patent of a Subject Invention, in any country, not less than thirty (30) 30 calendar days before the expiration of the response period required by the relevant patent office. iv. Regeneron Subcontractor shall include, within the specification of any United States U.S. patent application and any patent issuing thereon covering a Subject Invention, the following statement: “This invention was made with Government support under Agreement MCDC2020-504HHSO100201500029C, awarded by the U.S. Department of Health and Human ServicesHHS. The Government has certain rights in the invention.”

Action to Protect the Government’s Interest. Regeneron 1. The Performer agrees to execute or to have executed and promptly deliver to the Government DARPA all instruments necessary to (i) establish or confirm the rights the Government has throughout the world in those Subject Inventions to which Regeneron the Performer elects to retain title, and (ii) convey title to the Government DARPA when requested under Subparagraph c paragraph D of this Section 7.2 Article and to enable the Government to obtain patent protection throughout the world in that Subject Invention. i. Regeneron 2. The Performer agrees to require, by written agreement, its employees, other than clerical and non-technical employees, to disclose promptly in writing to personnel identified as responsible for the administration of patent matters and in a format suggested by Regeneron, the Performer each Subject Invention made under this Agreement so Regeneron in order that the Performer can comply with the disclosure provisions of paragraph C of this Section 7.2Article. Regeneron The Performer shall use reasonable efforts to instruct employees, through employee agreements or other suitable educational programs, on the importance of reporting inventions in sufficient time to permit the filing of patent applications prior to U.S. U. S. or foreign statutory bars. ii3. Regeneron The Performer shall notify the Government DARPA of any decisions not to continue the prosecution of a patent application for a Subject Inventionapplication, pay maintenance fees, or defend in a reexamination or opposition proceedings on a patent of a Subject Inventionpatent, in any country, not less than thirty (30) calendar days before the expiration of the response period required by the relevant patent office. 4. Regeneron The Performer shall include, within the specification of any United States patent application and any patent issuing thereon covering a Subject Invention, the following statement: “"This invention was made with Government support under Agreement MCDC2020HR0011-50412-3-0006, awarded by the U.S. Department of Health and Human ServicesDARPA. The Government has certain rights in the invention.”"

Action to Protect the Government’s Interest. Regeneron agrees to 1. The Seller shall execute or to have executed and promptly deliver to the Government via the Buyer all instruments necessary to (i) establish or confirm the rights the Government has throughout the world in those Subject Inventions to which Regeneron the Seller elects to retain title, and (ii) convey title to the Government when requested under Subparagraph c Paragraph D of this Section 7.2 Article X, and to enable the Government to obtain patent protection throughout the world in that Subject Invention. i. Regeneron 2. The Seller agrees to require, by written agreement, that its employeesemployees working on Projects, other than clerical and non-technical employees, agree to disclose promptly in writing to personnel identified as responsible for the administration of patent matters and in a format suggested by Regeneronpatent, each Subject Invention made Made under this Agreement so Regeneron in order that the Buyer, on behalf of the Seller, can comply with the disclosure provisions of this Section 7.2the prime OTA’s Paragraph C of Article X, and to execute all papers necessary to file the patent applications on the Subject Invention, and establish the Government’s rights in the Subject Invention. Regeneron The Seller acknowledges and shall use reasonable efforts to instruct employees, its employees through employee agreements or other suitable educational programs, on the importance of reporting inventions Inventions in sufficient time to permit the filing of patent applications prior to U.S. or foreign statutory bars. ii3. Regeneron The Seller shall notify the Government of any decisions decision not to continue the prosecution of a patent application for a Subject Inventionapplication, pay maintenance fees, fees or defend in a reexamination or opposition proceedings proceeding on a patent of a Subject Inventionpatent, in any country, not less than thirty (30) calendar days before the expiration of the response period required by the relevant patent office. 4. Regeneron The Seller shall include, within the specification of any United States patent application and any patent issuing thereon covering a Subject Invention, the following statement: “This invention was made with U.S. Government support under Agreement MCDC2020No. W9124P-19-504, 9-0001 awarded by the U.S. Department of Health and Human ServicesArmy Contracting Command-Redstone Arsenal to the AMTC. The Government has certain rights in the invention.”

Action to Protect the Government’s Interest. Regeneron The Performer agrees to execute or to have executed and promptly deliver to the Government DARPA all instruments necessary to (i) establish or confirm the rights the Government has throughout the world in those Subject Inventions subject inventions to which Regeneron the Performer elects to retain title, and (ii) convey title to the Government DARPA when requested under Subparagraph c paragraph D of this Section 7.2 Article and to enable the Government to obtain patent protection throughout the world in that Subject Invention. i. Regeneron subject invention. The Performer agrees to require, by written agreement, its employees, other than clerical and non-technical employees, to disclose promptly in writing to personnel identified as responsible for the administration of patent matters and in a format suggested by Regeneron, the Performer each Subject Invention subject invention made under this Agreement so Regeneron in order that the Performer can comply with the disclosure provisions of paragraph C of this Section 7.2Article. Regeneron The Performer shall use reasonable efforts to instruct employees, through employee agreements or other suitable educational programs, on the importance of reporting inventions in sufficient time to permit the filing of patent applications prior to U.S. U. S. or foreign statutory bars. ii. Regeneron The Performer shall notify the Government DARPA of any decisions not to continue the prosecution of a patent application for a Subject Inventionapplication, pay maintenance fees, or defend in a reexamination or opposition proceedings on a patent of a Subject Inventionpatent, in any country, not less than thirty (30) calendar days before the expiration of the response period required by the relevant patent office. Regeneron The Performer shall include, within the specification of any United States patent application and any patent issuing thereon covering a Subject Inventionsubject invention, the following statement: “This invention was made with Government support under Agreement MCDC2020No. HR0011-50411-9-0006, awarded by the U.S. Department of Health and Human ServicesDARPA. The Government has certain rights in the invention.”

Action to Protect the Government’s Interest. Regeneron agrees to execute or to have executed and promptly deliver to the Government all instruments necessary to (i) establish or confirm the rights the Government has throughout the world in those Subject Inventions to which Regeneron elects to retain title, and (ii) convey title to the Government when requested under Subparagraph c of this Section 7.2 and to enable the Government to obtain patent protection throughout the world in that Subject Invention. i. Regeneron agrees to require, by written agreement, its employees, other than clerical and non-non- technical employees, to disclose promptly in writing to personnel identified as responsible for the administration of patent matters and in a format suggested by Regeneron, each Subject Invention made under this Agreement so Regeneron can comply with the disclosure provisions of this Section 7.2. Regeneron shall use reasonable efforts to instruct employees, through employee agreements or other suitable educational programs, on the importance of reporting inventions in sufficient time to permit the filing of patent applications prior to U.S. or foreign statutory bars. ii. Regeneron shall notify the Government of any decisions not to continue the prosecution of a patent application for a Subject Invention, pay maintenance fees, or defend in a reexamination or opposition proceedings on a patent of a Subject Invention, in any country, not less than thirty (30) calendar days before the expiration of the response period required by the relevant patent office. Regeneron shall include, within the specification of any United States patent application and any patent issuing thereon covering a Subject Invention, the following statement: “This invention was made with Government support under Agreement MCDC2020-504, awarded by the U.S. Department of Health and Human Services. The Government has certain rights in the invention.”thirty

Action to Protect the Government’s Interest. Regeneron 1. Recipient agrees to execute or to have executed and promptly deliver to the Government HHS all instruments necessary to (i) establish or confirm the rights the Government has throughout the world in those Subject Inventions to which Regeneron Recipient elects to retain title, and (ii) convey title to the Government HHS when requested under Subparagraph c section D of this Section 7.2 Article and to enable the Government to obtain patent protection throughout the world in that Subject Invention. i. Regeneron 2. Recipient agrees to require, by written agreement, its employees, other than clerical and non-technical employees, to disclose promptly in writing writing, to personnel identified as responsible for the administration of patent matters and in a format suggested by RegeneronRecipient, each Subject Invention made under this Agreement so Regeneron in order that Recipient can comply with the disclosure provisions of section C of this Section 7.2Article. Regeneron Recipient shall use reasonable efforts to instruct employees, through employee agreements or other suitable educational programs, on the importance of reporting inventions Subject Inventions in sufficient time to permit the filing of patent applications prior to U.S. U. S. or foreign statutory bars. ii3. Regeneron Recipient shall notify the Government HHS of any decisions not to continue the prosecution of a patent application for claiming a Subject Invention, pay maintenance feesfees on a patent claiming a Subject Invention, or defend in a reexamination or opposition proceedings on a patent of claiming a Subject Invention, in any country, not less than thirty (30) calendar days before the expiration of the response period required by the relevant patent office. 4. Regeneron Recipient shall include, within the specification of any United States patent application and any patent issuing thereon covering claiming a Subject Invention, the following statement: “This invention was made with Government support under Agreement MCDC2020-504HHSO100201700018C, awarded by the U.S. Department of Health and Human ServicesHHS. The Government has certain rights in the invention.”

Action to Protect the Government’s Interest. Regeneron 1. The CONTRACTOR agrees to execute or to have executed and promptly deliver to the Government Agreements Officer with a copy to ULA all instruments necessary to (i) establish or confirm the rights the Government has throughout the world in those Subject Inventions to which Regeneron the CONTRACTOR elects to retain title, and (ii) convey title to the Government when requested under Subparagraph c paragraph C of this Section 7.2 Clause and to enable the Government to obtain patent protection throughout the world in that Subject Invention. i. Regeneron 2. The CONTRACTOR agrees to require, by written agreementContract, its employees, other than clerical and non-technical employees, to disclose promptly in writing to personnel identified as responsible for the administration of patent matters and in a format suggested by Regeneron, the CONTRACTOR each Subject Invention made under this Agreement so Regeneron Contract in order that the CONTRACTOR can comply with the disclosure provisions of paragraph B of this Section 7.2clause. Regeneron The CONTRACTOR shall use reasonable efforts to instruct employees, through employee agreements contracts or other suitable educational programs, on the importance of reporting inventions Inventions in sufficient time to permit the filing of patent applications prior to U.S. or foreign statutory bars. ii3. Regeneron The CONTRACTOR shall notify the Government Agreements Officer of any decisions not to continue the prosecution of a patent application for a Subject Inventionapplication, pay maintenance fees, or defend in a reexamination or opposition proceedings on a patent of a Subject Inventionpatent, in any country, not less than thirty (30) calendar days before the expiration of the response period required by the relevant patent office. 4. Regeneron The CONTRACTOR shall include, within the specification of any United States patent application and any patent issuing thereon covering a Subject Invention, the following statement: “This invention Invention was made with Government support under Agreement MCDC2020Contract No. FA8811-50415-9-0001, awarded by the U.S. Department of Health and Human ServicesSMC/LR. The Government has certain rights in the inventionInvention.”